GRAIL, Inc. (GRAL)
NASDAQ: GRAL · Real-Time Price · USD
40.73
-7.03 (-14.72%)
At close: Feb 21, 2025, 4:00 PM
40.15
-0.58 (-1.42%)
After-hours: Feb 21, 2025, 7:47 PM EST
GRAIL Employees
GRAIL had 1,360 employees as of December 31, 2023.
Employees
1,360
Change
n/a
Growth
n/a
Revenue / Employee
$92,349
Profits / Employee
-$1,490,445
Market Cap
1.38B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 1,360 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 440,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 72,000 |
GRAL News
- 1 day ago - GRAIL to Present at TD Cowen 45th Annual Health Care Conference - PRNewsWire
- 1 day ago - GRAIL, Inc. (GRAL) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 2 days ago - GRAIL Reports Fourth Quarter and Full Year 2024 Financial Results - PRNewsWire
- 10 days ago - GRAIL to Announce Fourth Quarter 2024 Financial Results - PRNewsWire
- 10 days ago - GRAIL and Quest Diagnostics Provide GRAIL's Galleri® Multi-Cancer Early Detection (MCED) Test Through the Quest Diagnostics Test Ordering System - PRNewsWire
- 26 days ago - Watch These Grail Price Levels After Med Tech Company's Stock Soared 64% Last Week - Investopedia
- 4 weeks ago - Early Cancer Detection Firm Grail Leads Nasdaq Gainers as Stock Jumps 20% - Investopedia
- 5 weeks ago - Patient Reported Outcomes for GRAIL's Galleri® Multi-Cancer Early Detection Blood Test Published in Lancet Oncology - PRNewsWire